Polymorphic Forms Of Rad1901-2Hcl

Patent No. EP3565542 (titled "Polymorphic Forms Of Rad1901-2Hcl") was filed by Radius Pharmaceuticals on Jan 5, 2018. The application was issued on Apr 10, 2024.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICAL INDUSTRIES LTDJan 10, 2025VON KAUFFMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3565542

RADIUS PHARMACEUTICALS
Application Number
EP18736577A
Filing Date
Jan 5, 2018
Status
Granted And Under Opposition
Mar 8, 2024
Publication Date
Apr 10, 2024